A DETAILED METHODOLOGY FOR RAILROAD COSTS. REPORT NO. 24

K R DeVol , J R Gallagher , W H Crown

1980
Costes del tratamiento con nuevos antidepresivos en la práctica clínica

T R Hylan , W H Crown , J A Sacristán , I Gilaberte
Atencion Primaria 23 ( 1) 15 -25

9
1999
Treatment costs of venlafaxine and selective serotonin-reuptake inhibitors for depression and anxiety.

Ernst R Berndt , William H Crown , Davina Ling , Stan N Finkelstein
Managed care interface 15 ( 6) 24 -30

5
2002
The cost of psoriasis.

William H Crown
Managed care (Langhorne, Pa.) 12 10

3
2003
A framework to evaluate the economic impact of pharmacogenomics

Sarah C Stallings , Dan Huse , Stan N Finkelstein , William H Crown
Pharmacogenomics 7 ( 6) 853 -862

29
2006
Predicting Onset of Dementia Using Clinical Notes and Machine Learning: Case-Control Study.

Christopher A Hane , Vijay S Nori , William H Crown , Darshak M Sanghavi
JMIR medical informatics 8 ( 6)

1
2020
Measuring the costs and benefits of pharmaceutical expenditures.

William H Crown , Davina Ling , Ernst Berndt
Expert Review of Pharmacoeconomics & Outcomes Research 2 ( 5) 467 -475

6
2002
Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.

Douglas E Levy , Stacey D Byfield , Catherine B Comstock , Judy E Garber
Genetics in Medicine 13 ( 4) 349 -355

155
2011
SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study.

Timothy R Hylan , Laurie Meneades , William H Crown , Jose A Sacristan
Journal of Affective Disorders 52 ( 1) 111 -119

10
1999
Applications of propensity score methods in observational comparative effectiveness and safety research: where have we come and where should we go?

Bijan J Borah , James P Moriarty , William H Crown , Jalpa A Doshi
Journal of Comparative Effectiveness Research 3 ( 1) 63 -78

22
2014
Antidepressant selection and use and healthcare expenditures: an empirical approach

William H Crown , Timothy R Hylan , Laurie Meneades
Pharmacoeconomics 13 ( 4) 435 -448

49
1998
SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis

Timothy R Hylan , William H Crown , Laurie Meneades , John H Heiligenstein
Medical Care 37 ( 4) AS36 -AS44

45
1999
Utilization and cost of health care services associated with primary malignant brain tumors in the United States

Lucie Kutikova , Lee Bowman , Stella Chang , Stacey R Long
Journal of neuro-oncology 81 61 -65

41
2007
An exploratory analysis of the medicaid expenditures of substance exposed children under 2 years of age in California

Marilyn Rymer Ellwood , E Kathleen Adams , William H Crown , Suzanne Dodds
Washington, DC: US Department of Health and Human Services, Office of the Assistance Secretary for Planning and Evaluation

4
1993
Derivation of an annualized claims-based major adverse cardiovascular event estimator in type 2 diabetes

Rozalina G McCoy , Kavya Sindhu Swarna , Yihong Deng , Jeph S Herrin
JACC: Advances 3 ( 4) 100852 -100852

2
2024
ASTHMA, RHINITIS, OTHER RESPIRATORY DISEASES-Treating allergic rhinitis in patients with comorbid asthma: The risk of asthma-related hospitalizations and emergency department

Jodi Crystal-Peters , Cheryl Neslusan , William H Crown , Amelito Torres
Journal of Allergy and Clinical Immunology 109 ( 1) 57 -62

2
2002
American Clusters: Using Machine Learning to Understand Health and Health Care Disparities in the United States

Diana M Bowser , Kaili Maurico , Brielle A Ruscitti , William H Crown
Health Affairs Scholar qxae017 -qxae017

1
2024